348 related articles for article (PubMed ID: 11305905)
1. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
[TBL] [Abstract][Full Text] [Related]
2. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
Hitomi K; Ikura K; Maki M
Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human recombinant transglutaminase 1 purified from baculovirus-infected insect cells.
Hitomi K; Yamagiwa Y; Ikura K; Yamanishi K; Maki M
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2128-37. PubMed ID: 11129585
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage.
Summey BT; Graff RD; Lai TS; Greenberg CS; Lee GM
J Orthop Res; 2002 Jan; 20(1):76-82. PubMed ID: 11853093
[TBL] [Abstract][Full Text] [Related]
5. Fas-induced caspase denitrosylation.
Mannick JB; Hausladen A; Liu L; Hess DT; Zeng M; Miao QX; Kane LS; Gow AJ; Stamler JS
Science; 1999 Apr; 284(5414):651-4. PubMed ID: 10213689
[TBL] [Abstract][Full Text] [Related]
6. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.
Xu L; Eu JP; Meissner G; Stamler JS
Science; 1998 Jan; 279(5348):234-7. PubMed ID: 9422697
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case A; Stein RL
Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.
Feng JF; Readon M; Yadav SP; Im MJ
Biochemistry; 1999 Aug; 38(33):10743-9. PubMed ID: 10451369
[TBL] [Abstract][Full Text] [Related]
9. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme.
Upchurch HF; Conway E; Patterson MK; Maxwell MD
J Cell Physiol; 1991 Dec; 149(3):375-82. PubMed ID: 1683874
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-kappa B by S-nitrosylation.
Marshall HE; Stamler JS
Biochemistry; 2001 Feb; 40(6):1688-93. PubMed ID: 11327828
[TBL] [Abstract][Full Text] [Related]
11. Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells.
Lai TS; Liu Y; Li W; Greenberg CS
FASEB J; 2007 Dec; 21(14):4131-43. PubMed ID: 17609251
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP.
Lai TS; Slaughter TF; Peoples KA; Hettasch JM; Greenberg CS
J Biol Chem; 1998 Jan; 273(3):1776-81. PubMed ID: 9430726
[TBL] [Abstract][Full Text] [Related]
13. Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity.
Nicholas B; Smethurst P; Verderio E; Jones R; Griffin M
Biochem J; 2003 Apr; 371(Pt 2):413-22. PubMed ID: 12533191
[TBL] [Abstract][Full Text] [Related]
14. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase.
Lai TS; Bielawska A; Peoples KA; Hannun YA; Greenberg CS
J Biol Chem; 1997 Jun; 272(26):16295-300. PubMed ID: 9195933
[TBL] [Abstract][Full Text] [Related]
15. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.
Iismaa SE; Wu MJ; Nanda N; Church WB; Graham RM
J Biol Chem; 2000 Jun; 275(24):18259-65. PubMed ID: 10747935
[TBL] [Abstract][Full Text] [Related]
16. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells.
Erwin PA; Lin AJ; Golan DE; Michel T
J Biol Chem; 2005 May; 280(20):19888-94. PubMed ID: 15774480
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
[TBL] [Abstract][Full Text] [Related]
18. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
19. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of rat brain transglutaminase.
Ohashi H; Itoh Y; Birckbichler PJ; Takeuchi Y
J Biochem; 1995 Dec; 118(6):1271-8. PubMed ID: 8720146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
